Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
I am not sure that is completely correct Wyn. A lot of investors have bought at least some of the shares off the placements where the money directly goes to the Company and where you are actually contributing to the eventual success if it does happen.
We might have minor retraces along the way, but in my view I think we are on the path of a proper re-rate on the back of two phase 2 successes this time.
I think we will hear a lot more of Synairgen once NIH and ACTG network announce this in the next few days. For a minnow to successfully pass a phase 2 trial and be sponsored by the US Govt for a larger phase 3 trial costing tens of millions is a great achievement in my view. Right now the SP doesn't quite reflect the enormity of this, but in time will catch this on.
"The Options are issued under the Company's Long Term Incentive Plans and are exercisable up to 19 October 2031, subject to the achievement of appropriate performance criteria."
It doesn't seem like it can be exercisable immediately, but are subject to meeting some performance requirements. I am guessing for these new recruits a lot will depend on outcomes in the next 6-12 months. It would have been good to know what these performance requirements actually are.
A few more large after hour trades. Surely these can't be all sells. Definitely buys and accumulated by IIs.
20-Oct-21 17:04:46 164.888 322,914 Sell* 532.45k O
20-Oct-21 17:00:41 164.88812 98,417 Sell* 162.28k O
20-Oct-21 16:44:05 165.99823 95,003 Sell* 157.70k O
20-Oct-21 16:43:43 166.01184 95,490 Sell* 158.52k O
20-Oct-21 16:43:27 166.01694 47,222 Sell* 78.40k
I topped up £5k at 163p as well. With two successful phase 2 trials for both home and hospital trials in the middle of a pandemic with no end in sight and with the US Govt willing to invest tens of millions for a further phase 3 trial, logic dictates that being at £330m market cap still we can be the bargain of the century.
We are slowly witnessing the making of a multi £bn blockbuster if it eventually passes both a home use and hospital use phase 3 trial next year. For now a rerate to £3+ will do.
Absolutely, accumulating steadily and the SP has barely moved.
If I had to guess I would think it will be Monday morning next week. It's been a long time patiently waiting since 20th July 2020, and we could certainly do with another stellar Monday. Fingers crossed.
The way he spoke initially was very confidently. No way that seemed like he may have misspoke. I just topped up a small amount now, can do with some good news for once.
The warrants are exercisable at 7.5p so that is what they pay in the next 3 months if warrants exercised not 5p.
Must say I am very surprised at the short time period it is exercisable for. For once I am not feeling too disappointed with a placing even if it has put me a bit more in the red.
I suspect we are in a territory now where a majority of the PIs are sitting on losses. The risk with this is that the selling will be pretty much distressed if there is no real progress and not sure if there will be any SP support now. It was already evident with the low PI take up rate in the placing showing no confidence in the company in my view. It will eventually find a bottom someday but you really have to be brave to catch a falling knife and risk even more capital and possible losses.
Now am 50% underwater on this one, just not been a good buy so far, and I thought I had got in at a good price recently at 45p that time when it was 75% below it's all time high. The only good thing was not taking part in the recent placing. Will just be happy to get my capital back someday.
https://www.theguardian.com/business/2021/oct/01/welsh-scientist-makes-potential-539m-fortune-from-biotech-flotation-in-us
Interesting article today. How long can we stay so undervalued?
In my opinion I don't think there is any confidence that SFX01 works even after a positive phase 2 trial although there are definitely encouraging signs with all the recent studies. I think that is why we sit on a pittance of a market cap. We need to definitely prove our mettle further before we perhaps can come a bit more on the radar of large pharmas. Not saying it can't or won't happen, but my belief is that the probability is low at least now until we get some success in one of the planned trials next year. I would be over the moon of course if something does come to fruition early.
Just shot up to 175p. Let's hope this is a precursor to some actual news this time rather than another false dawn.
Hopefully we will get another TR1 to confirm on the new buyer. It's still surprising that the SP has stayed so low and we are so under the radar while all these large trades take place. Perhaps there is another large seller or the MMs have been filling a large order from PIs selling cheaply over the last few weeks.
Just as I post, it's Kight who has been increasing his stake. Holding RNS just in.
All the large buys in the last couple of days which may or may not be Kight is definitely not punt money. My curiosity and excitement is building up that perhaps something big is happening in the background. Let's hope it's not a false dawn.
Could be a leak with the sudden rise. We will know soon.